SANTA
CLARA, Calif., June 23,
2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq:
SMLR), a company that develops, manufactures and markets innovative
medical products and services that assist in evaluating and
treating chronic diseases, today announced that it is set to join
the Russell 2000® and 3000® Indexes at
the conclusion of the 2023 Russell indexes annual reconstitution,
effective after the US market opens on June
26, 2023.
Annual Russell indexes reconstitution captures the 4,000 largest
US stocks as of April 28, 2023,
ranking them by total market capitalization. Membership in the US
all-cap Russell 3000® Index, which remains in place for
one year, means automatic inclusion in the large-cap Russell
1000® Index or small-cap Russell
2000® Index as well as the appropriate growth and
value style indexes. FTSE Russell determines membership for its
Russell indexes primarily by objective, market-capitalization
rankings and style attributes.
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for
active investment strategies. Approximately $12.1 trillion in assets are benchmarked against
Russell's US indexes. Russell indexes are part of FTSE Russell, a
leading global index provider.
For more information on the Russell 3000® Index and
the Russell indexes reconstitution, go to the "Russell
Reconstitution" section on the FTSE Russell website.
About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets
innovative products and services that assist in evaluating and
treating chronic diseases. Its flagship product,
QuantaFlo®, which is patented and cleared by the U.S.
Food and Drug Administration (FDA), is a rapid point-of-care test
that measures arterial blood flow in the extremities. The
QuantaFlo® test aids in the diagnosis of cardiovascular
diseases, such as peripheral arterial disease (PAD) and heart
dysfunction (HD). QuantaFlo® is used by healthcare
providers to evaluate their patient's risk of mortality and major
adverse cardiovascular events (MACE). In addition, Semler
Scientific has an agreement with Mellitus Health, Inc. (Mellitus)
to exclusively market and distribute Insulin Insights™, an
FDA cleared software product that recommends optimal insulin dosing
for diabetic patients in the United
States, including Puerto
Rico. Semler Scientific has a minority investment in
Mellitus, as well as Monarch Medical Technologies LLC, a privately
held company whose product EndoTool® offers a
technological solution for inpatient glycemic management.
Additional information about Semler Scientific can be found at
www.semlerscientific.com.
About FTSE Russell:
FTSE Russell is a global index leader that provides innovative
benchmarking, analytics and data solutions for investors worldwide.
FTSE Russell calculates thousands of indexes that measure and
benchmark markets and asset classes in more than 70 countries,
covering 98% of the investable market globally.
FTSE Russell index expertise and products are used extensively
by institutional and retail investors globally. Approximately
$20.1 trillion is currently
benchmarked to FTSE Russell indexes. For over 30 years, leading
asset owners, asset managers, ETF providers and investment banks
have chosen FTSE Russell indexes to benchmark their investment
performance and create ETFs, structured products and index-based
derivatives.
A core set of universal principles guides FTSE Russell index
design and management: a transparent rules-based methodology is
informed by independent committees of leading market participants.
FTSE Russell is focused on applying the highest industry standards
in index design and governance and embraces the IOSCO Principles.
FTSE Russell is also focused on index innovation and customer
partnerships as it seeks to enhance the breadth, depth and reach of
its offering.
FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com.
INVESTOR CONTACTS:
Susan A. Noonan
S.A. Noonan Communications
susan@sanoonan.com
917 513 5303
View original content to download
multimedia:https://www.prnewswire.com/news-releases/semler-scientific-to-join-the-russell-2000-and-3000-indexes-301861272.html
SOURCE Semler Scientific, Inc.